<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="128934">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01423630</url>
  </required_header>
  <id_info>
    <org_study_id>2008/517</org_study_id>
    <nct_id>NCT01423630</nct_id>
  </id_info>
  <brief_title>Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver</brief_title>
  <official_title>Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Probiotics and fruit fibre are given for 12 weeks to patients with fatty liver disease.

      The hypothesis is that probiotic bacteria and fruit fibre affect the gut microbial
      composition in a positive manner. The improved ecological system is believed to contribute
      to improved liver health and thereby counteract fatty liver disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improved and normalized liver status</measure>
    <time_frame>after 12 weeks intervention</time_frame>
    <description>normalized concentrations of liver enzymes in plasma. Magnetic resonanse imaging (compared to magnetic resonanse imaging before intervention) will also be used in the investigation of improved liver status.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in the gut bacterial flora</measure>
    <time_frame>after 12 weeks intervention</time_frame>
    <description>Changes and differences of the gut bacterial flora will be addressed in detail, e.g. changes in concentration of specific bacterial groups (e.g. Lactobacillus) before and after the intervention period.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Fatty Liver</condition>
  <arm_group>
    <arm_group_label>Probiotics and fruit fibre</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Probiotics and fruit fibre</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotics and fruit fibre</intervention_name>
    <description>probiotics and fruit fibre</description>
    <arm_group_label>Probiotics and fruit fibre</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  be able to participate in magnetic resonance imaging

        Exclusion Criteria:

          -  unable to understand oral and written information
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bengt Jeppsson, MD, PhD</last_name>
    <email>bengt.jeppsson@med.lu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ingrid Palmquist</last_name>
    <email>Ingrid.Palmquist@med.lu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Skåne University Hospital</name>
      <address>
        <city>Malmö</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingrid Palmquist</last_name>
      <email>Ingrid.Palmquist@med.lu.se</email>
    </contact>
    <contact_backup>
      <last_name>Bengt Jeppsson, MD, PhD</last_name>
      <email>bengt.jeppsson@med.lu.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 5, 2013</lastchanged_date>
  <firstreceived_date>August 23, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fatty liver</keyword>
  <keyword>probiotics</keyword>
  <keyword>Lactobacillus</keyword>
  <keyword>fruit</keyword>
  <keyword>fibre</keyword>
  <keyword>dietary intervention</keyword>
  <keyword>obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fatty Liver</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
